Ponte Vedra Beach, Florida, United States
Contact Info
882 followers
500+ connections
Ponte Vedra Beach, Florida, United States
Contact Info
882 followers
500+ connections
Activity
-
Beacon Therapeutics Holdings Limited announced it has raised $170 million in Series B funding, which will be used to support the continued clinical…
Beacon Therapeutics Holdings Limited announced it has raised $170 million in Series B funding, which will be used to support the continued clinical…
Liked by David Fellows
-
Proud moment for Axovia Therapeutics! Our Chief Scientific Officer, Dr Victor Hernandez, delivered an insightful presentation on the first gene…
Proud moment for Axovia Therapeutics! Our Chief Scientific Officer, Dr Victor Hernandez, delivered an insightful presentation on the first gene…
Liked by David Fellows
Experience & Education
-
Beacon Therapeutics
View David’s full experience
See their title, tenure and more.
or
More activity by David
-
Beacon Therapeutics have successfully raised a $170 Million in Series B funding, which the U.K.-based gene therapy biotech will use to push its eye…
Beacon Therapeutics have successfully raised a $170 Million in Series B funding, which the U.K.-based gene therapy biotech will use to push its eye…
Liked by David Fellows
-
A Summer full of great news for nAMD patients continues after receiving FDA approval to reintroduce Susvimo in the USA.
A Summer full of great news for nAMD patients continues after receiving FDA approval to reintroduce Susvimo in the USA.
Liked by David Fellows
-
Beacon Therapeutics has raised a $170 million series B, which the U.K.-based gene therapy biotech will use to push its eye disease candidates through…
Beacon Therapeutics has raised a $170 million series B, which the U.K.-based gene therapy biotech will use to push its eye disease candidates through…
Liked by David Fellows
-
Update #Eyedisease #opthalmology #funding #genetherapy #Precisionmedicine Beacon Therapeutics Forbion Syncona Limited Oxford Science Enterprises…
Update #Eyedisease #opthalmology #funding #genetherapy #Precisionmedicine Beacon Therapeutics Forbion Syncona Limited Oxford Science Enterprises…
Liked by David Fellows
-
𝐁𝐞𝐚𝐜𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐑𝐚𝐢𝐬𝐞𝐬 $𝟏𝟕𝟎 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝐒𝐞𝐫𝐢𝐞𝐬 𝐁 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 Beacon Therapeutics Beacon…
𝐁𝐞𝐚𝐜𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐑𝐚𝐢𝐬𝐞𝐬 $𝟏𝟕𝟎 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝐒𝐞𝐫𝐢𝐞𝐬 𝐁 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 Beacon Therapeutics Beacon…
Liked by David Fellows
-
Beacon Therapeutics raises $170 million in Series B financing. Beacon is a leading ophthalmic gene therapy company with a purpose to save and…
Beacon Therapeutics raises $170 million in Series B financing. Beacon is a leading ophthalmic gene therapy company with a purpose to save and…
Liked by David Fellows
-
Advent Life Sciences is thrilled to join Beacon Therapeutics in their journey to becoming a leading retinal gene therapy company. We are proud to…
Advent Life Sciences is thrilled to join Beacon Therapeutics in their journey to becoming a leading retinal gene therapy company. We are proud to…
Liked by David Fellows
-
#PortfolioNews - Congratulations to David Fellows and the team at Beacon Therapeutics for securing $170 million in its Series B funding. We are…
#PortfolioNews - Congratulations to David Fellows and the team at Beacon Therapeutics for securing $170 million in its Series B funding. We are…
Liked by David Fellows
-
We are thrilled to announce the successful closing of our $170 million Series B, led by Forbion with contributions from existing investors Syncona…
We are thrilled to announce the successful closing of our $170 million Series B, led by Forbion with contributions from existing investors Syncona…
Liked by David Fellows
-
Forbion is pleased to announce that we have led a $170 million in Series B funding for Beacon Therapeutics. We were joined by TCGX, and Advent Life…
Forbion is pleased to announce that we have led a $170 million in Series B funding for Beacon Therapeutics. We were joined by TCGX, and Advent Life…
Liked by David Fellows
-
Today Syncona announced it has committed $42.5 million to a $170 million Series B financing of its portfolio company Beacon Therapeutics. Beacon is…
Today Syncona announced it has committed $42.5 million to a $170 million Series B financing of its portfolio company Beacon Therapeutics. Beacon is…
Liked by David Fellows
-
We have a special team at Terns and are so fortunate that Scott Harris chose to join us as Chief Development Officer. It is truly a privilege to…
We have a special team at Terns and are so fortunate that Scott Harris chose to join us as Chief Development Officer. It is truly a privilege to…
Liked by David Fellows
-
We have more exciting news to share on the clinical trial front! The Retina Foundation has enrolled the first patient in Beacon Therapeutics’ VISTA…
We have more exciting news to share on the clinical trial front! The Retina Foundation has enrolled the first patient in Beacon Therapeutics’ VISTA…
Liked by David Fellows
-
Beacon Therapeutics is pleased to announce that the first patient has been treated in our Phase 2/3 VISTA clinical trial for our lead asset…
Beacon Therapeutics is pleased to announce that the first patient has been treated in our Phase 2/3 VISTA clinical trial for our lead asset…
Liked by David Fellows
-
Join our dynamic team at Beacon Therapeutics (USA) Inc. as a Full Time Associate Director in Quality Assurance Operations! This is an exciting…
Join our dynamic team at Beacon Therapeutics (USA) Inc. as a Full Time Associate Director in Quality Assurance Operations! This is an exciting…
Liked by David Fellows
-
It was a great time last week at the BioFlorida, Inc. Celebration of #Biotech! Thank you to our full team in #Alachua for helping to prepare for…
It was a great time last week at the BioFlorida, Inc. Celebration of #Biotech! Thank you to our full team in #Alachua for helping to prepare for…
Liked by David Fellows
-
Azadeh Kia and Ben Rigby were honored to represent Beacon Therapeutics at the Foundation Fighting Blindness (FFB) UK launch and inaugural Vision…
Azadeh Kia and Ben Rigby were honored to represent Beacon Therapeutics at the Foundation Fighting Blindness (FFB) UK launch and inaugural Vision…
Liked by David Fellows
People also viewed
-
Gwenaelle Pemberton
Connect -
Mark Gaffney
Connect -
Anna Dreismann
Connect -
Amy Christenson
Connect -
Sue Washer
Executive Leadership | Life Sciences, Biotech, Cell and Gene Therapy
Connect -
Friedrich Asmus, MD
Connect -
Eduardo Jacobo
Connect -
Emil Kuriakose, MD
Connect -
Senthil Sundaram
Connect -
Doreen Hoffman, SHRM CP
HR Generalist III at Beacon Therapeutics
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named David Fellows in United States
76 others named David Fellows in United States are on LinkedIn
See others named David Fellows